Actinogen Medical is a biotechnology company that is listed on ASX and specializes in developing innovative therapies for neurological diseases such as those associated with dysregulated brain cortisol. The company's flagship product is Xanamem® which is designed to decrease the production of intracellular cortisol, commonly known as the stress hormone through the inhibition of the 11β-HSD1 enzyme present in the brain.
Actinogen Medical's ticker is ACW
The company's shares trade on the ASX stock exchange
They are based in Sydney, Australia
There are 1-10 employees working at Actinogen Medical
It is https://actinogen.com.au/
Actinogen Medical is in the Healthcare sector
Actinogen Medical is in the Biotechnology industry
The following five companies are Actinogen Medical's industry peers: